RevoGen Biologics, LLC – Trademark Portfolio
Entity Type: 16
RevoGen Biologics, LLC holds 17 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 15 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 4 trademarks are registered and 9 are pending. Notable registered marks include BIO-STRAND FIBERS, REVOGEN BIOLOGICS, REVOSHIELD AMNIOTIC BARRIER, and REVOGEN BIOLOGICS REVOLUTIONIZING BIOREGENERATION. The owner is based in San Antonio, TX.
1583 Thousand Oaks Dr, Ste 103
San Antonio, TX 78232
Showing of trademarks Trademarks
Trademark Classifications
RevoGen Biologics, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does RevoGen Biologics, LLC have?
RevoGen Biologics, LLC has 17 U.S. trademarks filed with the USPTO. Of these, 4 registered, 9 pending, 4 abandoned.
What trademark classes does RevoGen Biologics, LLC file in?
RevoGen Biologics, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are RevoGen Biologics, LLC's most well-known trademarks?
RevoGen Biologics, LLC's registered trademark portfolio includes well-known marks such as BIO-STRAND FIBERS, REVOGEN BIOLOGICS, REVOSHIELD AMNIOTIC BARRIER, and REVOGEN BIOLOGICS REVOLUTIONIZING BIOREGENERATION. These are among 4 currently registered trademarks in the portfolio.
What is RevoGen Biologics, LLC's trademark registration success rate?
RevoGen Biologics, LLC has a 50% trademark registration rate, with 4 out of 8 resolved applications resulting in successful registration. Currently, 9 applications are pending review.